Metacon, in cooperation with its distribution and EPC partner Hydroholding, has entered into a new contract for supplying an additional Hydrogen Refuelling Station (HRS) unit in Slovakia. This follows the delivery of the first micro-HRS unit ordered earlier in the year. The contract value is 2,1 MSEK at the current EUR-SEK exchange rate.
The European HRS market is developing fast, linked to increasing market needs and a rapidly maturing base of available hydrogen-driven heavy and light vehicles. Metacon and Hydroholding have received a new order for a micro-HRS solution for refuelling FCEVs with hydrogen at 350 bar. After the initial first order earlier in 2022, a second order has now been placed to support the development of the hydrogen market in Slovakia and showcase the availability of H2 refuelling technology for transport to the public.
Under the contract, Metacon will supply a fully containerised small-HRS unit with a compression module, a dispenser module, and a control unit. To the micro-HRS unit, Hydroholding will supply hydrogen via a bottle rack system as well as installation and maintenance services.
Johan Berggren, Head of Sales of Metacon said: "The European market for hydrogen refuelling stations has started to grow and we expect it to grow fast over many years, driven by the accelerating green energy and fuel transition. This is our second HRS in a series of stations to Hydroholding in Slovakia and to the central European market".
Marek Roth, General Manager, at Hydroholding commented; "Hydroholding is, together with its key partner Metacon, going to deliver another hydrogen refuelling station in Slovakia. We are pleased to be a part of this booming market in our region and participate in the transition of various industries to a more sustainable and CO2-neutral stage. Further installations should follow in the near future, including larger HRSs and technology for production and storage of hydrogen".
This information is information that Metacon AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person below, on 21 November 2022 at 15:00 CET
For further information, please contact Johan Berggren, Head of Sales of Metacon, by phone +46 (0)73 500 7136 or by e-mail firstname.lastname@example.org.
About Metacon AB (publ)
Metacon AB (publ) develops and manufactures energy systems for the production of hydrogen, heat and electricity. The core products are based on a patented technology that, through so called catalytic steam reforming of biogas or other hydrocarbons, generates hydrogen. The development of Metacon's reforming products is done within the wholly owned subsidiary Helbio, which is a spin-off from the University of Patra, Greece and was founded by Professor Xenophon Verykios in 2001. From the onset, the business has focused on catalysts and advanced reforming for high-efficiency hydrogen production.
Metacon also offers system solutions for the production of hydrogen through electrolysis, a large and globally growing area for small and large-scale production of green hydrogen. Electrolysis is a process of starting and driving a chemical reaction to split water by adding electricity. If the electricity used is non-fossil and green, the hydrogen will also become completely climate neutral and green. Green hydrogen can be used in, for example, the transport sector, the basic industry and the real estate sector with a better environment and climate as a result. https://metacon.se/
Hydroholding is a supplier of hydrogen related technologies and system integrator. With a strong management background in the business with traditional petrol stations, Hydroholding aspires to offer turn-key solutions in the rapidly growing market of alternative fuels, with specialization on hydrogen in its whole production cycle - from production, through storage and transportation, to dispersion via HRSs.
Additional information may be found at
www.metacon.com | Twitter: @Metaconab | LinkedIn: www.linkedin.com/company/metaconab